Access cutting-edge pneumococcal disease treatment through this clinical trial at a research site in Sioux City. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Sioux City location
Access pneumococcal disease specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pneumococcal disease treatment provided free
Check if you qualify for this pneumococcal disease clinical trial in Sioux City, IA
No-Cost Study Care
Local to Sioux City
Convenient for IA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study is a Phase 3, randomized, modified double-blind study which aims to measure whether the investigational pneumococcal conjugate vaccine PCV21 is safe and can help the body to develop germ-fighting agents called "antibodies" (immunogenicity) when it is given after 1 dose, 2 doses, or 3 doses of a licensed 20-valent pneumococcal vaccine compared to when 20-valent pneumococcal vaccine is given as a complete series in infants aged from approximately 2 months (42 to 89 days). The study dur
Sponsor: Sanofi
Yes, this clinical trial (NCT06824181) has an active research site in Sioux City, IA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for pneumococcal disease treatment options in Sioux City, IA, this clinical trial (NCT06824181) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Sioux City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pneumococcal disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all pneumococcal disease clinical trials near you to find additional studies recruiting in your area.
See all ankylosing spondylitis clinical trials recruiting in Sioux City — not just this study.
Browse Ankylosing Spondylitis Trials in Sioux City →